IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Eloxx Pharmaceuticals Inc

CUSIP: 29014R103 | 110 institutional holders

Quarters

Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13GAberdeen Group plc400,0009.9%New 5%+ stakeJun 30, 2026Not yet in a 13F
13GAberdeen Group plc400,000

Institutional Holders — Q4 2022

Clal Insurance Enterprises Holdings Ltd14,626
0.0% of portfolio›$27
StyleTurnoverLocationFiled
Clal Insurance Enterprises Holdings Ltd
14,626$270.0%ETFMediumTel-Aviv, Luxembourg2023-02-13
9.9% of class · Jun 30, 2026
New 5%+ stake
Not yet in a 13F